NCT06725108

Brief Summary

The goal of this observational study is to explore the relationship of heart function with the course and outcomes after traumatic brain injuries and nontraumatic intracerebral hemorrhage. The goal is to explore association between routinely collected hemodynamic and brain monitoring data. Participants already taking intervention A as part of their regular medical care and the investigators will follow up with participants 6 months after discharging the hospital.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
7mo left

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Dec 2024Dec 2026

First Submitted

Initial submission to the registry

December 5, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

December 6, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 10, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 6, 2026

Last Updated

March 4, 2026

Status Verified

March 1, 2026

Enrollment Period

2 years

First QC Date

December 5, 2024

Last Update Submit

March 3, 2026

Conditions

Keywords

HemodynamicAcute brain injuryMonitoring

Outcome Measures

Primary Outcomes (1)

  • functional outcomes

    Primary endpoints are functional outcomes and quality of life at 180 days after hospital discharge. The follow-up functional status and quality of life measures will be done by telephone, in-person at their regularly scheduled follow-up appointment, or by email, for less than 30 minutes using validated instruments and/or using a web-based REDCap survey. However, these surveys can also be completed during the subject's 180-day follow up visit with their doctor or a telephone follow-up. The follow up telephone call/visit will last for less than 30 minutes and will consist of a series of validated instruments/questionnaires. The following instruments will be used: Glasgow Outcome Scale Extended (GOSE) to ascertain functional status The GOSE score ranges from 1 to 8, with the minimum score of 1 indicating Death and the highest score of 8 representing a Good Recovery, signifying a good outcome and a return to pre-injury functioning.

    180 days after discharging the hospital

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Admitted to the University of Chicago Medical Center Neurocritical Care Unit

You may qualify if:

  • Patients who are:
  • Admitted to the University of Chicago Medical Center Neurocritical Care Unit
  • Adults between 18 years and 80
  • Admitted with Traumatic brain injury blunt and penetrating or nontraumatic intracerebral hemorrhage
  • post-resuscitation Glasgow Coma Scale (GCS) \<9

You may not qualify if:

  • Patients who were:
  • Pre-existing heart failure
  • Moribund or neurological exam suggesting imminent brain death (bilateral, fixed and dilated pupils) on admission
  • Major polytrauma or admitted to the surgical trauma critical care service
  • Prisoner

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chicago

Chicago, Illinois, 60637, United States

RECRUITING

MeSH Terms

Conditions

Brain Injuries, TraumaticCerebral HemorrhageBrain Injuries

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesIntracranial HemorrhagesCerebrovascular DisordersVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Christos Lazaridis, MD

    university of Chicago attending

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2024

First Posted

December 10, 2024

Study Start

December 6, 2024

Primary Completion (Estimated)

December 6, 2026

Study Completion (Estimated)

December 6, 2026

Last Updated

March 4, 2026

Record last verified: 2026-03

Locations